key: cord-0259135-jg7r4uyo authors: Matias, W. R.; Fulcher, I. R.; Sauer, S. M.; Nolan, C. P.; Guillaume, Y.; Zhu, J.; Molano, F. J.; Uceta, E.; Collins, S.; Slater, D. M.; Sanchez, V. M.; Moheed, S.; Harris, J. B.; Charles, R. C.; Paxton, R. M.; Gonsalves, S. F.; Franke, M. F.; Ivers, L. C. title: Disparities in SARS-CoV-2 exposure: evidence from a citywide seroprevalence study in Holyoke, Massachusetts, USA date: 2021-10-14 journal: nan DOI: 10.1101/2021.10.13.21264975 sha: 44c14cefe4a6f9030da15897b10e2b2d00041b11 doc_id: 259135 cord_uid: jg7r4uyo Background: Seroprevalence studies are important tools to estimate the prevalence of prior or recent SARS-CoV-2 infections, identifying hotspots and high-risk groups and informing public health responses to the COVID-19 pandemic. We conducted a city-level seroprevalence study in Holyoke, Massachusetts, USA to estimate the seroprevalence of SARS-CoV-2 antibodies and risk factors for seropositivity. Methods: We invited inhabitants of 2,000 randomly sampled addresses between November 5 and December 31, 2020. Participants completed questionnaires measuring sociodemographic and health characteristics, and COVID-19 exposure history, and provided dried blood spots for measurement of SARS-CoV-2 IgG and IgM antibodies. We calculate total and subgroup seroprevalence estimates based on presence of IgG antibodies using a Bayesian procedure that incorporates uncertainty in antibody test sensitivity and specificity. We account for clustering by household and weighting based on demographic characteristics to ensure estimates represented the citys population. Findings: We enrolled 280 households including 472 individuals. 328 underwent antibody testing. The citywide seroprevalence estimate of SARS-CoV-2 IgG was 13.1% (95%CI 6.9-22.3) compared to 9.8% based on publicly reported case counts. Seroprevalence was 16.1% (95%CI 6.2-31.8) among individuals identifying as Hispanic compared to 9.4% (95%CI 4.6-16.4) among those identifying as non-Hispanic white. Seroprevalence was higher among Spanish speaking households (21.9%; 95% CI 8.3-43.9) compared to English speaking households (10.2%; 95% CI 5.2-18.0) and among individuals living in high vulnerability areas (14.4%; 95% CI 7.1-25.5) compared to low vulnerability areas (8.2%; 95% CI 3.1-16.9). Interpretation: The measured SARS-CoV-2 seroprevalence of IgG antibodies in Holyoke was only 13.1% during the second surge of SARS-CoV-2 in this region, far from accepted thresholds for herd immunity. Already vulnerable communities were at highest risk of prior infection. Implementation of local serosurveys in tandem with proactive public health interventions that address disparities in SARS-CoV-2 exposure are crucial to ensure at-risk communities have appropriate educational materials and access to vaccines, testing, and timely treatment. Evidence before this study 73 The implementation of our seroepidemiologic study in Holyoke, Massachusetts December 2020 74 was informed by both the (1) variation in SARS-CoV-2 seroprevalence from surrounding 75 communities and (2) lack of information on risk of SARS-CoV-2 infection by race and ethnicity 76 status. Specifically, a serosurvey using convenience sampling of asymptomatic individuals in the 77 predominantly Hispanic community of Chelsea, MA, during April 2020 demonstrated a high 78 seroprevalence of 31.5%. This serosurvey was limited by non-representative convenience 79 sampling that likely resulted in a biased estimate in addition to the use of a rapid lateral flow 80 immunoassay with imperfect test accuracy. In July and August 2020, a university-related 81 population and their household members in Massachusetts demonstrated a much lower 82 seroprevalence between 4-5.3%. To our knowledge, these were the only two seroepidemiologic 83 surveys in searchable databases at the time of this study. Globally, a recent systematic review 84 and meta-analysis of SARS-CoV-2 serosurveys through December 2020 demonstrated 85 significant regional variability in seroprevalence estimates and associated risk factors and 86 highlighted similar methodological constraints as described above. Thus, our goal was to conduct 87 a local serosurvey with the aim of informing community-tailored public health responses for at-88 risk groups, using population-representative sampling methods, and accounting for uncertainty in 89 test performance characteristics. 90 91 Added value of this study 92 We found that the seroprevalence of SARS-CoV-2 IgG antibodies was 13.1% during the second 93 wave, far from acceptable levels of herd immunity, but also discrepant from the COVID-19 94 testing data from the city, which reported a prevalence of 9.6%. Hispanic and Latino/a 95 individuals, individuals from Spanish-speaking households, and individuals living in areas with a 96 high social vulnerability index had higher seroprevalence of SARS-CoV-2 IgG antibodies, 97 indicating that already vulnerable communities were at a higher risk of prior infection. We 98 utilized a novel Bayesian analytic approach to account for the sensitivity and specificity of the 99 antibody test, while ensuring our study population reflected the population of Holyoke. 100 101 Implications of all the available evidence 102 Our findings highlight the need for wide implementation of population-representative local 103 serosurveys to ensure local details are not masked by findings at the state and national levels. In 104 tandem with locally implemented serosurveys, proactive public health interventions will be 105 crucial to respond to disparities in infection risk that will likely continue to propagate in the 106 absence of further interventions. 107 108 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 10 sites during the first surge in 2020 documented a seroprevalence ranging between 1.0% in the 123 San Francisco Bay area and 6.9% in New York City. 4 In addition to regional variability, most 124 SARS-CoV-2 serosurveys have suffered from several methodological constraints, predominantly 125 related to non-representative sampling protocols and inaccuracies in serologic assays. 126 127 In the US, the Commonwealth of Massachusetts (MA), fueled by a super-spreader event of 128 SARS-CoV-2, became one of the early epicenters of the pandemic. 5 Table 1) . Notably, gender is reported as the percent of "Female persons" in 216 Holyoke in the ACS survey results, such that we only have two categories for gender: Female 217 and non-Female, which includes male, transgender, and non-binary persons. For the purposes of 218 constructing weights, we collapsed sparse categories of race and ethnicity into a "Grouped 219 category". The census tracts were also collapsed into "high vulnerability" and "low 220 vulnerability" groups based on the social vulnerability index (SVI). 15 High vulnerability was 221 defined as having an SVI greater than the 75 th percentile of census tracts in Massachusetts -9 of 222 the 11 census tracts were considered high. Table 1 . Individuals from younger age groups and individuals 260 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 14, 2021. We investigated seroprevalence by medical conditions and COVID-19 symptoms, testing, and 290 exposure history ( Figure 2) . Notably, the seroprevalence estimate of individuals reporting any of 291 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) were younger and had attained lower education levels (Table 4) . They had higher rates of 302 unemployment at the start of the pandemic and were more likely to have their salary impacted by 303 COVID-19. They were more likely to work at a place that offered no benefits such as paid sick 304 leave or work-from-home and were more likely to use the bus as a means of transportation. 305 Housing conditions were also different, with Hispanic/Latino/Latina individuals more likely to 306 live in apartments or condominiums, rent instead of owning their homes, and report a higher 307 density of individuals living in the household. 308 With regards to the relationship between seropositivity and SARS-CoV-2 exposure history, this 355 study corroborates recent findings. Seroprevalence was higher among individuals with a 356 COVID-19 exposure that was a household member compared to an exposure to a non-household 357 member. This finding highlights the greater importance of intra-household exposures compared 358 to exposure to non-household members. 23 Given the role of intra-household transmission, public 359 health interventions and resources should be targeted to preventing transmission in the 360 household, such as providing isolation and quarantine sites outside the home, appropriate PPE 361 for individuals taking care of sick family members, timely and sequential testing for exposed 362 household members, and guidance on how to safely distance within the home. This study has several limitations. First, the small sample size led to estimates with wide 95% 396 credible intervals, precluding us from formally comparing seroprevalence between groups and 397 conducting multivariable analyses. Second, our analysis does not account for waning antibody 398 levels, which decay over time. 11 Third, because we did not interview individuals that declined to 399 participate or did not respond to survey invitation, it is possible that non-response bias may be 400 affecting our findings, though we proactively followed up with households that did not respond 401 to the study via telephone calls and home visits. Fourth, this study was conducted using a single 402 assay. Several studies have shown that variation in the sensitivity and specificity of the serologic 403 test used in a serosurvey can affect seroprevalence estimates. 29 To limit the effect of this, we 404 used a test that had previously been validated in Massachusetts and conducted a sensitivity 405 analysis using other plausible test sensitivity and specificity values. Finally, we excluded nursing 406 homes and congregate living facilities from this study. Holyoke has a high density of such 407 facilities, and early on during the pandemic suffered a large outbreak at one of these. 30 However, 408 our goal was to assess community-level epidemiology, as community transmission seems to now 409 be the major driver of the pandemic. In conclusion, in this SARS-CoV-2 serosurvey of Holyoke, Massachusetts, between November 414 2020 -January 2021, antibody prevalence was higher than prior serosurveys in the region, but 415 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 14, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Immunol. 2020;5(52). doi:10.1126/sciimmunol.abe0367 504 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 14, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 14, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 14, 2021. ; https://doi.org/10.1101/2021.10.13.21264975 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 14, 2021. ; https://doi.org/10.1101/2021.10.13.21264975 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 14, 2021. ; https://doi.org/10.1101/2021.10.13.21264975 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 Seroprevalence for demographics groups based on IgG antibody positivity (i.e., at least IgG positive). 2 N refers to the total numbers of individuals in each category. 3 n refers to the total number of individuals seropositive for IgG in each group. 4 Weights were computed as the inverse probability of selection and adjusted so that the marginal distribution of age group, gender, race/ethnicity, and social vulnerability index of the sample agreed with population estimates. * Among adult respondents only. + Among individuals that responded "Yes" to working outside the home during the "stay at home" order. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 14, 2021. ; https://doi.org/10.1101/2021.10.13.21264975 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 Respondents excluded if missing response for a certain variable * Among adult respondents only. ** Among individuals that responded "Yes" to working outside the home during the "stay at home" order. *** Symptoms include cough, sore throat, chills, shortness of breath, fever, body aches, nausea, loss of smell, loss of appetite, fatigue, headache. **** Assistances include: WIC, TANF, SSI, Public medical insurance, unemployment insurance, COVID-19 related stimulus payment, Food pantry/Food basket support. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 14, 2021. ; https://doi.org/10.1101/2021.10.13.21264975 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 14, 2021. ; https://doi.org/10.1101/2021.10.13.21264975 doi: medRxiv preprint Figure 2 . Seroprevalence by Medical, Symptom, Testing and Exposure History * n refers to the number of individuals that tested positive. N refers to the total number of individuals that responded "Yes" to the given question. ** being contact-traced refers to individuals that reported being contacted by public health agencies in Massachusetts and told that they were in contact with a person with COVID-19. + Three individuals that did not remember their test results and four individuals that had not received their test results at the time of the survey. Results are for people that reported getting at least one test. Weighted Seroprevalence (95% CI) Testing, exposure C Characteristic ** . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 14, 2021. ; https://doi.org/10.1101/2021.10.13.21264975 doi: medRxiv preprint Substantial underestimation of SARS-CoV-2 471 infection in the United States Estimation of US SARS-CoV-2 Infections Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys Serological evidence of human infection with SARS-477 CoV-2: a systematic review and meta-analysis Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites 480 in the United States Phylogenetic analysis of SARS-CoV-2 in Boston 483 highlights the impact of superspreading events State COVID-19 data show Holyoke, Northampton hardest-hit area communities Coronavirus Hot Spots: The 50 Mass. Communities With the Highest Rates of Cases Dried Blood Spots for Measuring Vibrio cholerae-495 specific Immune Responses